SCHEMBL3846896

SCHEMBL3846896

Cc1ccn(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4c(F)cccc4F)cc23)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 16/20 0.36
CYP1A2 P05177 15/20 0.36
CYP2C19 P33261 14/20 0.36
ALDH1A1 P00352 13/20 0.36
CLK4 Q9HAZ1 12/20 0.36
CYP2D6 P10635 8/20 0.36
LMNA P02545 7/20 0.36
HSD17B10 Q99714 3/20 0.36
TP53 P04637 3/20 0.36
ALOX15 P16050 2/20 0.36
CYP2C9 P11712 2/20 0.36
MAP4K4 O95819 1/20 0.35
TSHR P16473 10/20 0.35
MAPK1 P28482 8/20 0.35
HIF1A Q16665 7/20 0.35
USP2 O75604 5/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
HPGD P15428 3/20 0.33
TGFBR1 P36897 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846604 0.87 MAP4K4 (0.35) CYP3A4CYP1A2CYP2C19ALDH1A1CLK4
SCHEMBL3847529 0.86 CYP3A4 (0.40) CYP3A4CYP1A2CYP2C19ALDH1A1CLK4
SCHEMBL3844886 0.79 MAP4K4 (0.36) CYP3A4CYP1A2CYP2C19ALDH1A1CLK4
SCHEMBL3846904 0.79 CYP1A2 (0.38) CYP3A4CYP1A2CYP2C19ALDH1A1CLK4
SCHEMBL3848884 0.79 EGFR (0.39) CYP3A4CYP1A2CYP2C19ALDH1A1CYP2D6
SCHEMBL3845615 0.76 MAP4K4 (0.33) CYP3A4CYP1A2CYP2C19ALDH1A1CLK4
SCHEMBL3846029 0.76 MAP4K4 (0.33) MAP4K4
SCHEMBL3845778 0.74 MAP4K4 (0.32) CYP3A4CYP1A2CYP2C19CLK4CYP2D6
SCHEMBL3847718 0.73 MAPK14 (0.46) ALDH1A1CYP2D6TP53HPGDTGFBR1
SCHEMBL3847727 0.73 PIK3CD (0.41) CYP3A4CYP1A2CYP2C19ALDH1A1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed